导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.31% | 255/330 |
| 近一周 | 3.56% | 3/359 |
| 近一月 | 2.20% | 20/358 |
| 近一季 | 3.46% | 38/354 |
| 近半年 | 11.50% | 96/345 |
| 近一年 | 10.68% | 220/330 |
| 近两年 | 15.82% | 235/274 |
| 近三年 | 30.60% | 113/194 |
| 成立以来 | 234.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-6.03% 235/341 |
10.92% 124/349 |
6.89% 248/355 |
- - |
| 2024 | 4.68% 215/330 |
7.66% 83/280 |
-7.87% 276/310 |
3.11% 200/319 |
2.36% 122/330 |
| 2023 | 10.63% 83/276 |
16.86% 40/205 |
6.51% 87/230 |
-16.64% 229/262 |
6.61% 131/276 |
| 2022 | -14.94% 68/202 |
-9.74% 93/153 |
-14.60% 114/164 |
2.16% 18/189 |
8.01% 116/202 |
| 2021 | 15.98% 50/151 |
2.82% 110/312 |
7.90% 94/328 |
-6.76% 195/358 |
12.12% 14/151 |
| 2020 | 23.57% 26/104 |
-20.46% 215/280 |
20.91% 93/295 |
10.88% 43/299 |
15.87% 46/305 |
| 2019 | 27.72% 26/89 |
10.81% 108/258 |
5.29% 33/268 |
-0.68% 166/253 |
10.22% 73/266 |
| 2018 | -9.00% 46/80 |
- - |
- - |
- - |
-15.00% 170/241 |
| 2017 | 26.67% 16/69 |
- - |
- - |
- - |
- - |
| 2016 | 3.72% 32/59 |
- - |
- - |
- - |
- - |
| 2015 | 0.66% 21/49 |
- - |
- - |
- - |
- - |
| 2014 | -3.82% 79/99 |
- - |
- - |
- - |
- - |
| 2013 | 31.51% 3/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2715 | 30.30% |
| 易方达标普生物科技人民币A | 1.7172 | 27.30% |
| 易方达标普生物科技人民币C | 1.6936 | 27.21% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4590 | 19.43% |
| 广发生物科技指数美元(QDII)A | 0.2081 | 18.59% |
| 广发生物科技指数人民币(QDII)A | 1.4690 | 17.80% |
| 广发生物科技指数人民币(QDII)C | 1.4450 | 17.77% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3424 | 17.75% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币C | 1.3639 | 17.05% |
| 广发全球医疗保健指数人民币(QDII)C | 2.4880 | 10.94% |
| 易方达标普消费品指数A VS. 天弘恒生科技指数(QDII)C(012349) |